AEON Biopharma, Inc. Loss Contingency, Damages Sought, Value
AEON Biopharma, Inc. (AEON) had Loss Contingency, Damages Sought, Value of $1.59 million as of 2025-11-20, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyDamagesSoughtValue · last filed 2026-03-30
- 2025-11-20: Loss Contingency, Damages Sought, Value $1.59M.
| Period end | Loss Contingency, Damages Sought, Value |
|---|---|
| 2025-11-20 | $1.59M 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |